On #NationalCaregiversDay, we honor the dedication of caregivers everywhere. Your efforts make a world of difference. For those supporting loved ones battling a brain tumor, here is a list of resources from Brain Tumor Network: braintumornetwork.org/caregiver-reso…

ICYMI, we published our review, "Theranostic Uses of the Heme Pathway in Neuro-Oncology: Protoporphyrin IX (PpIX) and Its Journey from Photodynamic Therapy (PDT) through Photodynamic Diagnosis (PDD) to #SonodynamicTherapy (SDT)," in Cancers MDPI: mdpi.com/2072-6694/16/4…

Did you know that 1 in 5 cancers is considered rare, including #DIPG? On #RareDiseaseDay, we highlight the critical need for #raredisease research and support. Join us as we raise awareness and advocate for those affected by rare diseases. #RareDiseaseDay2024

Thank you, EndBrainCancer Initiative, for highlighting SonALAsense to help pediatric patients access SDT-201, our Phase 1/2 Clinical Trial using #SonodynamicTherapy for #DIPG brain tumors. Learn more: ktla.com/business/press…

On #InternationalWomensDay, we express our gratitude to women worldwide for their dedication, innovation, and pioneering spirit in #CancerResearch and the development of #cancer treatments. Thank you to the invaluable women on our team for their remarkable contributions. #IWD2024

Our science targets cancer’s need for heme, enabling specific targeting of cancer cells to trigger immediate and programmed cell death only in tumors, while sparing healthy tissue. Learn more about #SonodynamicTherapy: sonalasense.com/our-science #glioblastoma #DIPG #cancer

We'll be exhibiting at #AACR24 from 4/7-10 at the San Diego Convention Center. Stop by booth #4025 to discover how we're advancing our mission to create cancer survivors. Looking forward to connecting with you there! aacr.org/meeting/aacr-a…

SonALAsense was established to develop a new, noninvasive cancer-specific treatment to patients as soon as possible. Learn how our 30-year journey began: sonalasense.com/for-patients

We are honored to receive a $50K grant renewal award from the Rally Foundation for Childhood Cancer Research for our Phase 1/2 Study of #SonodynamicTherapy using SONALA-001 and Exablate 4000 Type 2 ultrasound device. See all the research that earned a 2024 grant: rallyfoundation.org/rally-foundati… #RallyOn #GOLDSTRONG

We’re here in San Diego at #AACR24! Stop by our booth #4025 and connect!

Are you searching for reliable DIPG resources? Check out My DIPG Navigator. This program provides dedicated Nurse Navigators offering reliable information to help families understand and manage care for their children battling #DIPG. mydipgnavigator.org

Thank you, to AACR, for orchestrating an exceptional conference! We're grateful for the opportunity to engage with fellow researchers, clinicians, and industry leaders, all working towards the same goal in the fight against cancer. #AACR24

Today, on #DIPGAwarenessDay, we unite in the fight against DIPG, a devastating pediatric brain cancer with a median survival of just 11 months. At SonALAsense, we're working on Sonodynamic therapy to treat DIPG. Learn more about our efforts here: lnkd.in/gGwqWkzs

SonALAsense is thrilled to have presented our SDT-201 interim report at #ASCO2024! SonALAsense showcased promising advancements in treating DIPG with sonodynamic therapy. #Oncology #SonodynamicTherapy #DIPG #MedicalResearch